fluconazole has been researched along with Tinea Pedis in 9 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Tinea Pedis: Dermatological pruritic lesion in the feet, caused by Trichophyton rubrum, T. mentagrophytes, or Epidermophyton floccosum.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We treated 20 patients who had tinea corporis and/or tinea cruris and 20 patients who had tinea pedis with oral fluconazole." | 9.07 | Therapy with fluconazole for tinea corporis, tinea cruris, and tinea pedis. ( Montero-Gei, F; Perera, A, 1992) |
| "The novel triazoles showed potent activity against dermatophytes and promising candidates for the treatment of tinea pedis caused by Trichophyton and Epidermophyton species." | 7.96 | Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis. ( Aala, F; Badali, H; Barac, A; Daie Ghazvini, R; Fatahi, N; Ghaffari, M; Hashemi, SJ; Izadi, A; Khodavaisy, S; Rezaie, S; Salehi, Z; Taran, M, 2020) |
| "Seventy adult out-patients with tinea pedis participated in a multicentre open non-comparative study of the safety and efficacy of once-weekly doses of oral fluconazole 150 mg." | 7.68 | Once-weekly oral doses of fluconazole 150 mg in the treatment of tinea pedis. ( Del Aguila, R; Gei, FM; Male, O; Perera-Ramírez, A; Robles, M, 1992) |
| "We treated 20 patients who had tinea corporis and/or tinea cruris and 20 patients who had tinea pedis with oral fluconazole." | 5.07 | Therapy with fluconazole for tinea corporis, tinea cruris, and tinea pedis. ( Montero-Gei, F; Perera, A, 1992) |
| "The novel triazoles showed potent activity against dermatophytes and promising candidates for the treatment of tinea pedis caused by Trichophyton and Epidermophyton species." | 3.96 | Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis. ( Aala, F; Badali, H; Barac, A; Daie Ghazvini, R; Fatahi, N; Ghaffari, M; Hashemi, SJ; Izadi, A; Khodavaisy, S; Rezaie, S; Salehi, Z; Taran, M, 2020) |
| "The efficacy of BCO was assessed in vitro and compared to that of the drugs currently utilized in the treatment of tinea versicolor (fluconazole and itraconazole) and tinea pedis (itraconazole and terbinafine)." | 3.88 | Blad-containing oligomer: a novel fungicide used in crop protection as an alternative treatment for tinea pedis and tinea versicolor. ( Carreira, A; Ferreira, J; Ferreira, JB; Ferreira, RB; Filipe, P; Monteiro, S; Pereira, I, 2018) |
| "The present study aimed to determine prevalences of tinea pedis and onychomycosis, factors predisposing to their development, and antifungal susceptibilities of causative fungal species against fluconazole, itraconazole, and terbinafine in patients with type 2 diabetes mellitus (DM)." | 3.85 | Prevalence and epidemiology of tinea pedis and toenail onychomycosis and antifungal susceptibility of the causative agents in patients with type 2 diabetes in Turkey. ( Balta, I; Oz, A; Oz, Y; Qoraan, I, 2017) |
| "Seventy adult out-patients with tinea pedis participated in a multicentre open non-comparative study of the safety and efficacy of once-weekly doses of oral fluconazole 150 mg." | 3.68 | Once-weekly oral doses of fluconazole 150 mg in the treatment of tinea pedis. ( Del Aguila, R; Gei, FM; Male, O; Perera-Ramírez, A; Robles, M, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Salehi, Z | 1 |
| Fatahi, N | 1 |
| Taran, M | 1 |
| Izadi, A | 1 |
| Badali, H | 1 |
| Hashemi, SJ | 1 |
| Rezaie, S | 1 |
| Daie Ghazvini, R | 1 |
| Ghaffari, M | 1 |
| Aala, F | 1 |
| Barac, A | 1 |
| Khodavaisy, S | 1 |
| Carreira, A | 1 |
| Ferreira, JB | 1 |
| Pereira, I | 1 |
| Ferreira, J | 1 |
| Filipe, P | 1 |
| Ferreira, RB | 1 |
| Monteiro, S | 1 |
| Oz, Y | 1 |
| Qoraan, I | 1 |
| Oz, A | 1 |
| Balta, I | 1 |
| Fritz, P | 1 |
| Beck-Jendroschek, V | 1 |
| Brasch, J | 1 |
| Méndez-Tovar, LJ | 1 |
| Manzano-Gayosso, P | 1 |
| Velásquez-Hernández, V | 1 |
| Millan-Chiu, B | 1 |
| Hernández-Hernández, F | 1 |
| Mondragón-González, R | 1 |
| López-Martínez, R | 1 |
| Stengel, F | 1 |
| Robles-Soto, M | 1 |
| Galimberti, R | 1 |
| Suchil, P | 1 |
| Del Aguila, R | 1 |
| Gei, FM | 1 |
| Robles, M | 1 |
| Perera-Ramírez, A | 1 |
| Male, O | 1 |
| Montero-Gei, F | 1 |
| Perera, A | 1 |
| Hansen, E | 1 |
2 trials available for fluconazole and Tinea Pedis
| Article | Year |
|---|---|
Fluconazole versus ketoconazole in the treatment of dermatophytoses and cutaneous candidiasis.
Topics: Adult; Candida; Candidiasis, Cutaneous; Double-Blind Method; Female; Fluconazole; Follow-Up Studies; | 1994 |
Therapy with fluconazole for tinea corporis, tinea cruris, and tinea pedis.
Topics: Administration, Oral; Adult; Drug Tolerance; Female; Fluconazole; Follow-Up Studies; Humans; Male; M | 1992 |
7 other studies available for fluconazole and Tinea Pedis
| Article | Year |
|---|---|
Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis.
Topics: Antifungal Agents; Arthrodermataceae; Dermatomycoses; Fluconazole; Griseofulvin; Humans; Imidazoles; | 2020 |
Blad-containing oligomer: a novel fungicide used in crop protection as an alternative treatment for tinea pedis and tinea versicolor.
Topics: Antifungal Agents; Arthrodermataceae; Crop Protection; Drug Discovery; Fluconazole; Fungicides, Indu | 2018 |
Prevalence and epidemiology of tinea pedis and toenail onychomycosis and antifungal susceptibility of the causative agents in patients with type 2 diabetes in Turkey.
Topics: Adult; Age Factors; Aged; Antifungal Agents; Arthrodermataceae; Case-Control Studies; Diabetes Melli | 2017 |
Inhibition of dermatophytes by the antimicrobial peptides human β-defensin-2, ribonuclease 7 and psoriasin.
Topics: Antifungal Agents; Arthrodermataceae; beta-Defensins; Epidermophyton; Female; Fluconazole; Humans; M | 2012 |
[Resistance to azolic compounds in clinical Trichophyton spp. strains].
Topics: Adult; Antifungal Agents; Cross Infection; Drug Resistance, Fungal; Drug Resistance, Multiple, Funga | 2007 |
Once-weekly oral doses of fluconazole 150 mg in the treatment of tinea pedis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Drug Administration Schedule; Female; Fluconazole; Hu | 1992 |
Fluconazole in the treatment of refractory oral candidiasis and tinea pedis in an elderly patient.
Topics: Aged; Candidiasis, Oral; Female; Fluconazole; Humans; Tinea Pedis | 1990 |